Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/31/2002US20020160360 Hybrid analysis; target binding efficiency
10/31/2002US20020160080 Animal feed additives
10/31/2002US20020160038 Cationic liposome containing cationic lipid, phosphatidylcholine and cholestrol; carrier for radiosensitizing tumor cells by administration of Human antisense c-raf-1 oligodeoxyribonucleotide
10/31/2002US20020160019 Providing peptide that bears a DR motif corresponding to a Class II HLA molecule, testing peptide for binding affinity to a Class II HLA DR molecule, whereupon an IC50 binding affinity is determined
10/31/2002US20020160018 For inducing in a bovine host an immunological response against bovine respiratory syncytial virus or bovine viral diarrhea virus
10/31/2002US20020160016 Modified surface antigen
10/31/2002US20020160015 Chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes and its uses
10/31/2002US20020160006 Methods of treating lymphoma and leukemia
10/31/2002US20020160004 Antibodies against flt3-ligand
10/31/2002US20020160003 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability
10/31/2002US20020160000 PD-1, a receptor for B7-4, and uses therefor
10/31/2002US20020159991 Modulation of Abeta levels by beta-secretase BACE2
10/31/2002US20020159990 Synergistic degradation of oligosaccharides by endoglucanases, resulting in the production of ethanol from complex cellulose substrates
10/31/2002US20020159979 Adeno- associated virus inverted terminal repeats flanking DNA sequences encoding an immunodeficiency virus protein operably linked to a promoter and polyadenylation sequences
10/31/2002US20020159978 RAAV virion(recominant adeno-associated virus) comprising an AAV-6 capsid, and a heterologous nucleic acid encoding Factor IX operably linked to expression control element, administering virion to a muscle cell
10/31/2002US20020159977 Administering a recombinant adeno-associated virion into human suffering from hemophilia such that factor VIII nuclotide sequence are expressed at a level which provide therapeutically effective amount in the patient
10/31/2002US20020159976 An isolated polynucleotide comprising a nucleotide sequence present in Lactobacillus rhamnosus strain HN001 that encodes a polypeptide having atleast one enzymetic activity; genetic engineering
10/31/2002US20020159958 Methods for producing immunoglobulins containing protection proteins in plants and their use
10/31/2002US20020158906 Method of displaying correlation between biopolymer and probe
10/31/2002US20020158017 Using isocratic mobile phase to elute polynucleic acid form Matched Ion Polynucleotide chromatogaraphy column
10/31/2002EP1082238A4 Reinforced beam assembly
10/31/2002DE10217066A1 Composition useful for treatment of central nervous system disorders, e.g. Alzheimer's disease comprises modulator of neuron-specific calcium sensor-1
10/31/2002DE10121283A1 Verfahren und Vektoren zur Amplifikation oder Expression von gewünschten Nucleinsäuresequenzen in Pflanzen Methods and vectors for amplification or expression of the desired nucleic acid sequences in plants
10/31/2002DE10121235A1 Verfahren zur Expression von Proteinen in in vitro Translations-Systemen unter Ko-Expression von Faltungshelferproteinen Methods for expression of proteins in in vitro translation systems under co-expression of chaperone proteins
10/31/2002DE10121113A1 Genmodifizierte YT Zelllinie und ihre Verwendung Genetically Modified YT cell line and their use
10/31/2002DE10119274A1 Enzymatisches Verfahren zur enantioselektiven Reduktion von Ketoverbindungen Enzymatic method for the enantioselective reduction of keto compounds
10/31/2002DE10118452A1 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Nucleic acid sequences of hyperplasias and tumors of the thyroid
10/31/2002CA2807478A1 Use of follistatin to increase muscle mass
10/31/2002CA2483507A1 Enzyme and snp marker for disease
10/31/2002CA2445354A1 Nucleic acid molecules encoding starch degrading enzymes
10/31/2002CA2445258A1 Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides
10/31/2002CA2445257A1 Circuit arrangement for injecting nucleic acids and other biologically active molecules into the nucleus of higher eucaryontic cells using electrical current
10/31/2002CA2445255A1 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002CA2445248A1 Nucleic acid analysis by mass differentiable oligomers
10/31/2002CA2445197A1 T1r3 a novel taste receptor
10/31/2002CA2445179A1 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002CA2445177A1 Method to analyse the kit genotype of pigs
10/31/2002CA2445168A1 Human timp-1 antibodies
10/31/2002CA2445071A1 Oligonucleotide compositions and their use to induce differentiation of cells
10/31/2002CA2445011A1 Transformed silkworm producing human collagen
10/31/2002CA2444994A1 Methods for high throughput genome analysis using restriction site tagged microarrays
10/31/2002CA2444967A1 Biological sample processing methods and compositions that include surfactants
10/31/2002CA2444945A1 Recombinant vaccinia viral vectors
10/31/2002CA2444857A1 Compositions and methods for the identification of protein interactions in vertebrate cells
10/31/2002CA2444797A1 Method of producing homozygous plants by transforming haploid somatic plant cells and chromosome doubling
10/31/2002CA2444743A1 Viral vectors having reduced virulence
10/31/2002CA2444691A1 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
10/31/2002CA2444683A1 Antimicrobial polypeptides and their uses
10/31/2002CA2444675A1 Secreted proteins
10/31/2002CA2444621A1 A method of nuclear transfer
10/31/2002CA2444617A1 Production of genetically modified plants with puroindolines
10/31/2002CA2444602A1 Anti-obesity polypeptides
10/31/2002CA2444536A1 Tomato plants that exhibit resistance to botrytis cinerea
10/31/2002CA2444235A1 New polynucleotides and polypeptides of the ifn.alpha.-17 gene
10/31/2002CA2444195A1 Compositions and methods for recombinational cloning of nucleic acid molecules
10/31/2002CA2444098A1 Methods and compositions for the production of orthogonal trna-aminoacyl trna synthetase pairs
10/31/2002CA2444006A1 Expression of core-glycosylated hcv envelope proteins in yeast
10/31/2002CA2443781A1 Core-glycosylated hcv envelope proteins
10/31/2002CA2443776A1 Amplification and detection of mycoplasma pneumoniae
10/31/2002CA2443757A1 In vivo incorporation of unnatural amino acids
10/31/2002CA2443740A1 Constructs and methods for expression of recombinant hcv envelope proteins
10/31/2002CA2443710A1 Biological sample processing methods and compositions that include surfactants
10/31/2002CA2443511A1 Multi-format sample processing devices, methods and systems
10/31/2002CA2443373A1 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002CA2441783A1 Genes involved in isoprenoid compound production
10/31/2002CA2441540A1 Replikin peptides and uses thereof
10/31/2002CA2441353A1 Single nucleotide polymorphisms diagnostic for schizophrenia
10/31/2002CA2439693A1 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
10/31/2002CA2439690A1 Modified interferon alpha with reduced immunogenicity
10/31/2002CA2438833A1 Lactic acid bacteria as agents for treating and preventing allergy
10/31/2002CA2438539A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/31/2002CA2436216A1 Methods for identifying the target of a compound which inhibits cellular proliferation
10/31/2002CA2429351A1 A novel human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/30/2002EP1253475A2 Electrostatic charge image developing toner, producing method therefor, and image forming method and image forming apparatus utilizing the toner
10/30/2002EP1253364A1 Ultralow expansion brake rubber hose and its production method
10/30/2002EP1253206A2 Method of amplifying or detecting hiv-1 rna
10/30/2002EP1253202A1 Expression cassette comprising the Arabidopsis thaliana trehalose-6-phosphate synthase 3 (TPS3) promoter for strong constitutive gene expression
10/30/2002EP1253201A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
10/30/2002EP1253200A1 Cocoa polypeptides and their use in the production of cocoa and chocolate flavour
10/30/2002EP1253199A1 Abasic moieties containing enzymatic nucleic acids
10/30/2002EP1253198A1 Plant adpglucose pyrophosphatase, method for the production thereof, its use in the production of assay devices and for obtaining transgenic plants
10/30/2002EP1253195A1 Process for producing l-lysine
10/30/2002EP1253160A2 Construct and method for making it
10/30/2002EP1252897A1 Drugs for gene therapy
10/30/2002EP1252894A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
10/30/2002EP1252818A1 Method of transferring mutant mitochondrial dna into genital cells
10/30/2002EP1252339A1 Synthesis of spatially addressed molecular arrays
10/30/2002EP1252337A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252335A1 Signaling aptamers that transduce molecular recognition to a differential signal
10/30/2002EP1252333A2 Methods and materials relating to cd84-like polypeptides and polynucleotides
10/30/2002EP1252332A2 Polynucleotide arrays and their use in sequencing
10/30/2002EP1252331A2 Methods and compositions for detection of mycobacterium avium complex species
10/30/2002EP1252330A2 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
10/30/2002EP1252328A2 Cell isolation method
10/30/2002EP1252323A2 Virus strains for the oncolytic treatment of cancer
10/30/2002EP1252322A2 Herpes virus strains for gene therapy
10/30/2002EP1252321A1 Replication deficient adenovirus vectors
10/30/2002EP1252320A2 Modified minimal promoters
10/30/2002EP1252319A2 Combinatorial protein domains
10/30/2002EP1252318A2 Allene oxide cyclase gene and use thereof for producing jasmonic acid
1 ... 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 ... 4023